Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 10.5% in the morning session after the company reported better-than-expected fourth-quarter results, highlighted by a smaller loss than ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...

Company Filings Reveal Massive, Undisclosed Warrant Exercises that Appear to Have Placed 10X’s Total Ownership of the Company Above the 5% SEC ...

We recently compiled a list of the 10 Stocks That Will Skyrocket. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks. The primary ...

Additionally, 10x Genomics reported revenue of $166 million, exceeding projections of $157.73 million. Despite these positive results, the company’s stock experienced a decline during regular trading ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 14.3% in the afternoon session after the company reported third-quarter financial results that beat Wall Street's expectations and provided ...